Crossmark

A systematic review and meta-analysis of efficacy and safety of Romosozumab in postmenopausal osteoporosis

Crossref DOI link: https://doi.org/10.1007/s00198-021-06095-y

Published Online: 2021-08-25

Published Print: 2022-01

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Singh, S. http://orcid.org/0000-0002-8990-3235
Dutta, S. http://orcid.org/0000-0001-6525-5950
Khasbage, S. http://orcid.org/0000-0003-3235-7197
Kumar, T. http://orcid.org/0000-0003-0593-2774
Sachin, J. http://orcid.org/0000-0003-1840-5279
Sharma, J. http://orcid.org/0000-0002-1029-9961
Varthya, S B http://orcid.org/0000-0002-7163-0400
License Information

Text and Data Mining valid from 2021-08-25

Version of Record valid from 2021-08-25
More Information

Article History

Received: 3 May 2021

Accepted: 8 August 2021

First Online: 25 August 2021

Declarations

:

: Not applicable.

: Not applicable.

: None.